Literature DB >> 18205071

Synthesis, characterization, and in vitro assay of folic acid conjugates of 3'-azido-3'-deoxythymidine (AZT): toward targeted AZT based anticancer therapeutics.

Anthony R Vortherms1, Robert P Doyle, Dayuan Gao, Olivia Debrah, Patrick J Sinko.   

Abstract

Conjugates of three components namely folic acid, poly(ethyleneglycol) and 3 '-azido-3 '-deoxythymidine (AZT) are presented. Folate-PEG units were coupled to AZT to facilitate delivery of the nucleoside into the cell. A convenient separation of the polydisperse PEGylated-folic acid regioisomers produced upon conjugation is described. This is to select for the active gamma-regioisomer over the inactive alpha-regioisomer. In vitro cytotoxicity assays were conducted against an ovarian cell line (A2780/AD) that overexpresses the folate receptor (FR) and compared to a FR free control cell line. Compared to AZT a approximately 20-fold greater potency against the resistant ovarian line was observed for the conjugates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205071      PMCID: PMC2729114          DOI: 10.1080/15257770701795946

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  40 in total

Review 1.  Folate receptor-targeted drugs for cancer and inflammatory diseases.

Authors:  Philip S Low; Asok C Antony
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

2.  Is stavudine triphosphate a natural metabolite of zidovudine?

Authors:  Henri Benech; François Becher; Alain Pruvost; Jacques J Grassi
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.

Authors:  J Y Feng; A A Johnson; K A Johnson; K S Anderson
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

4.  Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients.

Authors:  François Becher; Alain G Pruvost; Dimitri D Schlemmer; Christophe A Créminon; Cecile M Goujard; Jean François Delfraissy; Henri C Benech; Jacques J Grassi
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

5.  Folate receptor targeted biodegradable polymeric doxorubicin micelles.

Authors:  Hyuk Sang Yoo; Tae Gwan Park
Journal:  J Control Release       Date:  2004-04-28       Impact factor: 9.776

6.  Optimization of antiviral prodrug properties using combinatorial methods.

Authors:  Yulia V Berezovskaya; Mikhail V Chudinov; Alexander M Yurkevich
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2003 May-Aug       Impact factor: 1.381

Review 7.  Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase.

Authors:  Harold Lee; Jeremiah Hanes; Kenneth A Johnson
Journal:  Biochemistry       Date:  2003-12-23       Impact factor: 3.162

8.  Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

Authors:  Christopher P Leamon; Matthew A Parker; Iontcho R Vlahov; Le-Cun Xu; Joseph A Reddy; Marilynn Vetzel; Nikki Douglas
Journal:  Bioconjug Chem       Date:  2002 Nov-Dec       Impact factor: 4.774

9.  Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.

Authors:  Yonghua Zhang; Lili Guo; Roger W Roeske; Aśok C Antony; Hiremagalur N Jayaram
Journal:  Anal Biochem       Date:  2004-09-01       Impact factor: 3.365

10.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  3 in total

1.  Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism.

Authors:  Anthony R Vortherms; Hester N Dang; Robert P Doyle
Journal:  Clin Med Oncol       Date:  2009-03-20

Review 2.  Recent trends in targeted anticancer prodrug and conjugate design.

Authors:  Yashveer Singh; Matthew Palombo; Patrick J Sinko
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  Development of a folate receptor (FR)-targeted indenoisoquinoline using a pH-sensitive N-ethoxybenzylimidazole (NEBI) bifunctional cross-linker.

Authors:  Yuchen Cao; Jerry Yang
Journal:  Bioconjug Chem       Date:  2014-04-29       Impact factor: 4.774

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.